AI in Drug Design: From Hype to Real-World Results
By leveraging AI, drug developers are moving beyond incremental gains in efficiency and engaging previously undruggable targets.
By leveraging AI, drug developers are moving beyond incremental gains in efficiency and engaging previously undruggable targets.
Cognition is just one layer of the human experience, and as AI lifts the burden of thought, we may unlock deeper realms of creativity, intuition,…
Privately held Triana focuses on building a molecular glue pipeline developed through its platform, which is designed to identify small molecules that induce protein:protein interactions…
Lady European common frogs aren’t as helpless as previously thought
Build your AI-first strategy with a digital business platform
Directed Evolution (DE) is a method developed by Nobel laureate Frances Arnold to improve protein fitness for specific applications. However, DE can be less efficient…
Demonstrate the value of generative AI with a cloud-native platform
AI tools and hundreds of human proofreaders helped tease apart 140,000 neurons in a brain the size of a grain of sand
COVER This photograph shows a female standard fancy rat—a domesticated variant for the pet trade. That rats make good pets is not surprising when considering…
Enhance patient and staff experiences with generative AI
Developers are finding new ways to leverage mRNA and other modalities to prevent or defeat various infectious diseases.